Citation:Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P 2011

From Cancer Guidelines Wiki

Citation


Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011 Oct 13;365(15):1375-83 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/21995385.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the incidence of neoplasia in patients with BO?Associate Professor Freddy Sitascompleted
What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?Professor David Whiteman B Med Sci, MBBS (Hons) PhD FAFPHMcompleted
Are there groups of patients with non-dysplastic BO that require more frequent surveillance?Dr Henry Tocompleted
Are there groups of patients with BO that can be discharged from surveillance?Conjoint Associate Professor Philip Craigcompleted

Compare quality appraisals for each clinical question

Cited by

  1. Are there groups of patients with non-dysplastic BO that require more frequent surveillance?
  2. Is surveillance cost-effective for follow-up of patients with BO?
  3. What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?
  4. What is the incidence of neoplasia in patients with BO?